Betoptic S

  • Glaucoma

Betoptic S Generic Name & Formulations

General Description

Betaxolol HCl 0.25%; oph. susp; contains benzalkonium chloride.

Pharmacological Class

Cardioselective beta-blocker.

How Supplied

Susp—10mL, 15mL

Generic Availability


Betoptic S Indications


Open-angle glaucoma. Ocular hypertension.

Betoptic S Dosage and Administration

Adults and Children

Remove contact lenses before use; may reinsert 15mins after instillation. 1–2 drops twice daily.

Betoptic S Contraindications


Sinus bradycardia. Greater than 1st-degree AV block. Cardiogenic shock. Overt cardiac failure.

Betoptic S Boxed Warnings

Not Applicable

Betoptic S Warnings/Precautions


History of cardiac failure or heart block. Discontinue at 1st sign of cardiac failure. COPD. Asthma. Pulmonary impairment. Measure intraocular pressure during 1st month of treatment. Diabetes (esp. labile). Vascular insufficiency; consider alternative therapy if reduced cerebral blood flow or Raynaud's phenomenon develop. History of atopy or anaphylaxis. May mask hypoglycemia and hyperthyroidism. Discontinue before general anesthesia. Avoid abrupt cessation. Pregnancy. Nursing mothers.

Betoptic S Pharmacokinetics

See Literature

Betoptic S Interactions


May potentiate or be potentiated by systemic β-blockers. May potentiate reserpine, hypoglycemics. May antagonize adrenergic psychotropics. Additive hypotension and/or marked bradycardia with concomitant calcium antagonists, antiarrhythmics, digitalis.

Betoptic S Adverse Reactions

Adverse Reactions

Transient discomfort, tearing. Rarely: decreased corneal sensitivity, erythema, itch, corneal punctate staining, keratitis, anisocoria, photophobia, depression, headache, bradycardia, dyspnea, hives.

Betoptic S Clinical Trials

See Literature

Betoptic S Note

Not Applicable

Betoptic S Patient Counseling

See Literature